Literature DB >> 11218212

Lack of serological evidence for Mycoplasma fermentans infection in army Gulf War veterans: a large scale case-control study.

S C Lo1, L Levin, J Ribas, R Chung, R Y Wang, D Wear, J W Shih.   

Abstract

Mycoplasma firmentans is suspected in the development of 'Gulf War illness' in veterans of Operation Desert Storm. We conducted a matched case-control study for the prevalence of M. firmentans-specific antibodies before and after the operation, as well as seroconversion rates in veterans with and without complaints of 'Gulf War illness'. Cases consisted of Gulf War veterans, who complained of various illnesses and were enrolled in the second phase of the health evaluation by the Army Comprehensive Clinical Examination Program (CCEP). Controls were selected from Gulf War veterans who did not participate in the registry and did not request a health evaluation by the CCEP. Before operation deployment, 34 out of 718 of the cases (48%) and 116 out of 2233 of the controls (5.2%) tested positive for M. fermentans-specific antibodies. There was no difference in rates of seroconversion between cases and controls (1.1 vs. 1.2%) to M. fermentans during Operation Desert Storm. Thus, there is no serological evidence that suggests infectionby M. fermentans is associated with development of 'Gulf War illness'.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11218212      PMCID: PMC2869645          DOI: 10.1017/s0950268800004891

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  4 in total

Review 1.  The Defense Medical Surveillance System and the Department of Defense serum repository: glimpses of the future of public health surveillance.

Authors:  Mark V Rubertone; John F Brundage
Journal:  Am J Public Health       Date:  2002-12       Impact factor: 9.308

Review 2.  Mycoplasma blood infection in chronic fatigue and fibromyalgia syndromes.

Authors:  Gerhard K M Endresen
Journal:  Rheumatol Int       Date:  2003-07-16       Impact factor: 2.631

Review 3.  Description and utilization of the United States department of defense serum repository: a review of published studies, 1985-2012.

Authors:  Christopher L Perdue; Angelia A Eick Cost; Mark V Rubertone; Luther E Lindler; Sharon L Ludwig
Journal:  PLoS One       Date:  2015-02-27       Impact factor: 3.240

4.  Implications of new technology for infectious diseases practice.

Authors:  Ellen Jo Baron
Journal:  Clin Infect Dis       Date:  2006-10-10       Impact factor: 9.079

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.